Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
EClinicalMedicine
View this publicationEClinicalMedicine
View this publicationClinical immunology (Orlando, Fla.)
View this publicationFrontiers in immunology
View this publicationBMC medicine
View this publicationCytokine
View this publicationCell systems
View this publicationClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
View this publicationMicrobiology spectrum
View this publicationClinical obesity
View this publicationFrontiers in immunology
View this publication